Chapter 331 Scumbag! (Thanks to the leader of the Mobai Alliance in Qiancheng)

Chen Nan's words were really domineering.

It completely blinded everyone present!

"They...don't deserve it?!"

soon!

The audience fell into a discussion.

Yuan Chaomin and others looked confused. They looked at Chen Nan, obviously unable to understand Chen Nan's confidence in saying this.

Damn it!

They were really panicked inside.

They came to attend the conference and indeed learned a lot of professional knowledge and new drug concepts.

Yuan Chaomin, Lu Shouyue and others naturally hope that Chen Nan's drug will receive attention and publicity on this platform.

After all, this is the venue for the launch of the world’s top new cancer drugs.

But!

Chen Nan actually started to fire on the NMPA company directly here, saying that their second-generation sequencing has fallen behind and is not worthy of genetic testing at all.

These words instantly made everyone a little annoyed.

Sure enough, soon!

More people began to question Chen Nan.

After all, in addition to experts in the field of oncology, there were also many pharmaceutical companies launching new drugs.

What they got were also sequencing results from NMPA.

A targeted drug must pass sequencing to prove that it indeed has a targeting effect on cancer cells. Only then can it obtain the threshold standard for targeted drugs.

Otherwise, even the name "targeted drug" cannot be mentioned.

After Chen Nan was denied by the NMPA sequencing company, he directly targeted the opponent.

He even said that the other party was not worthy of sequencing.

How arrogant and domineering is this?

In an instant, more and more people in the audience began to accuse Chen Nan.

"This... Chen Nan is too arrogant!"

"Yes, NMPA sequencing company is the current international standard, who has the right to say that others are not worthy!"

"That's right! What qualifications does he have to deny NMPA's sequencing standards?"

"China has not even developed a targeted drug, and it is ridiculous to talk about qualifications!"

"Yes, I originally thought this young man was good, but his tone was too loud!"

…

For a time, more and more people began to question and even criticize Chen Nan's words.

On such a stage, one needs to speak with strength and discuss matters with evidence.

It's not who has a loud voice or a tough tone who is more likely to quarrel.

Seeing Chen Nan like this.

Joffrey, who was originally a little disgusted and angry towards Chen Nan, suddenly laughed at this moment.

He was originally a little worried about Chen Nan's new medicine.

The NMPA company actually directly denied the targeting effect of icariin.

Chen Nan even directly started to retaliate against the opponent here.

This immediately aroused heated discussion, and Joffrey didn't even need to stand up himself.

it's good now!

Chen Nan can be said to be surrounded by enemies on all sides.

No matter how many tongues he has, can he stop so many experts present?

Tilson has some dandruff and numbness.

Damn it, isn't Chen Nan too brave?

Yesterday, he directly criticized Gilead's Joffrey. Today, Gilead's stock price continues to slump.

To know!

Some time ago, Gilead's stock price could be said to be a very rare good thing.

Now it's good, many investors are beginning to hesitate.

The United States can be said to be a country where all people participate in stock trading, and many people’s savings are in the stock market.

Chen Nan's questions about Gilead yesterday were quickly published in relevant medical newspapers and magazines, causing the other company's shares to plummet instantly.

And today!

Chen Nan actually directly targeted NMPA Precision Medicine Company.

This operation made Tiersen's waist tremble a little.

but!

Most people showed strong disgust at Chen Nan's words!

Even Drizzt frowned a little at this time.

Although he doesn't like those profit-seeking pharmaceutical companies, there is no denying their contribution to the development of the pharmaceutical industry.

However, Chen Nan now directly criticized the NMPA, which made Drizzt a little unhappy.

Although the World New Cancer Drug Conference welcomes major new pharmaceutical products from all over the world, as long as they pass the review and have recommendations from regions or countries, they are eligible to enter this conference.

However, that doesn't mean you can talk nonsense.

soon!

Someone stood up.

This is Brooks, vice president of the Cancer Society.

Brooks stood up and looked at Chen Nan and said:

"Professor Chen, your speech yesterday was a speech with suggestions for the World Society of Oncology."

"But that doesn't mean you can talk nonsense!"

"The significance of the existence of NMPA has proven its value. Over the years, the strict review of targeted drugs has become something that the industry is aware of."

"The Food and Drug Administrations of many countries will accept and recognize each other's standards by default."

"I want to know why you evaluate each other so much?!"

"Is it just because you haven't obtained the certification from the other company?"

"If so, you are not a qualified oncology researcher."

Brooks' words attracted the attention of many people, and everyone started talking in low voices.

When Joffrey saw this scene, he was overjoyed.

It can be said that he has no good impression of Chen Nan now.

I wish that the other party would encounter difficulties from everyone.

Chen Nan heard the sound and said with a smile: "Sir, of course I am not talking nonsense."

"NMPA currently uses second-generation gene sequencing technology."

"But my drug, icariin, is a multi-molecule target drug."

"He failed the test, which is a very normal thing."

"In fact, starting from this point, it can also prove the shortcomings and loopholes of second-generation sequencing."

"Furthermore, I was not surprised that it failed to pass the other party's detection!"

"The truly great place of Akela Din lies here!

It is different from the drug synthesis of screening targets and is not a one-way gene target.

The shortcomings of second-generation sequencing are obvious. It cannot accurately predict gene fragments and can easily cause errors!

If it is a targeted drug that screens the target, it can be verified through screening.

but!

Akradine is a multi-target small molecule therapeutic drug!
To be continued...